These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 2470596

  • 1. Subchronic haloperidol treatment decreases the in vivo release of tachykinins in rat substantia nigra.
    Lindefors N, Brodin E, Ungerstedt U.
    Eur J Pharmacol; 1989 Feb 14; 161(1):95-8. PubMed ID: 2470596
    [Abstract] [Full Text] [Related]

  • 2. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
    Lindefors N, Brodin E, Tossman U, Segovia J, Ungerstedt U.
    Exp Brain Res; 1989 Feb 14; 74(3):527-34. PubMed ID: 2468514
    [Abstract] [Full Text] [Related]

  • 3. Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P- and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra.
    Humpel C, Saria A.
    Neurosci Lett; 1989 Oct 23; 105(1-2):159-63. PubMed ID: 2484728
    [Abstract] [Full Text] [Related]

  • 4. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
    Humpel C, Knaus GA, Auer B, Knaus HG, Haring C, Theodorsson E, Saria A.
    Synapse; 1990 Oct 23; 6(1):1-9. PubMed ID: 1697986
    [Abstract] [Full Text] [Related]

  • 5. Neuroleptic treatment induces region-specific changes in levels of neurokinin A and substance P in rat brain.
    Lindefors N, Brodin E, Ungerstedt U.
    Neuropeptides; 1986 Apr 23; 7(3):265-80. PubMed ID: 2423911
    [Abstract] [Full Text] [Related]

  • 6. Tachykinins in the rat substantia nigra: effects of selective dopamine receptor antagonists.
    Oblin A, Zivkovic B.
    Fundam Clin Pharmacol; 1991 Apr 23; 5(2):129-38. PubMed ID: 1712746
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo release of neurokinin A-like immunoreactivity from rat substantia nigra.
    Diez-Guerra FJ, Sirinathsinghji DJ, Emson PC.
    Neuroscience; 1988 Nov 23; 27(2):527-36. PubMed ID: 2905788
    [Abstract] [Full Text] [Related]

  • 8. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons.
    Bannon MJ, Lee JM, Giraud P, Young A, Affolter HU, Bonner TI.
    J Biol Chem; 1986 May 25; 261(15):6640-2. PubMed ID: 2422168
    [Abstract] [Full Text] [Related]

  • 9. In vivo detection of immunoreactive neurokinin A release within rat substantia nigra and its dependency on a dopaminergic input.
    Furmidge LJ, Duggan AW, Arbuthnott GW.
    Brain Res; 1995 May 15; 679(2):241-8. PubMed ID: 7633884
    [Abstract] [Full Text] [Related]

  • 10. Tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA.
    Sivam SP, Krause JE.
    J Neurochem; 1992 Dec 15; 59(6):2278-84. PubMed ID: 1279124
    [Abstract] [Full Text] [Related]

  • 11. Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A.
    Brodin E, Lindefors N, Dalsgaard CJ, Theodorsson-Norheim E, Rosell S.
    Regul Pept; 1986 Feb 15; 13(3-4):253-72. PubMed ID: 2422706
    [Abstract] [Full Text] [Related]

  • 12. Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system.
    Arai H, Emson PC.
    Brain Res; 1986 Dec 10; 399(2):240-9. PubMed ID: 2435360
    [Abstract] [Full Text] [Related]

  • 13. Substance P and neurokinin A, two coexisting tachykinins stimulating the release of [3H]5-HT from rat cerebral cortical slices.
    Iverfeldt K, Solti M, Bartfai T.
    Brain Res; 1990 Jan 08; 506(2):335-8. PubMed ID: 1689200
    [Abstract] [Full Text] [Related]

  • 14. Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation.
    Saria A, Martling CR, Yan Z, Theodorsson-Norheim E, Gamse R, Lundberg JM.
    Am Rev Respir Dis; 1988 Jun 08; 137(6):1330-5. PubMed ID: 2462373
    [Abstract] [Full Text] [Related]

  • 15. Comparison of responses by striatonigral substance P and neurokinin A systems to methamphetamine treatment.
    Hanson GR, Letter AA, Merchant K, Gibb JW.
    Peptides; 1986 Jun 08; 7(6):983-7. PubMed ID: 2436197
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
    Shirayama Y, Mitsushio H, Takahashi K, Nishikawa T.
    Synapse; 2000 Mar 15; 35(4):292-9. PubMed ID: 10657039
    [Abstract] [Full Text] [Related]

  • 17. Regional distribution of neuropeptide gamma and other tachykinin peptides derived from the substance P gene in the rat.
    Takeda Y, Takeda J, Smart BM, Krause JE.
    Regul Pept; 1990 May 21; 28(3):323-33. PubMed ID: 1696018
    [Abstract] [Full Text] [Related]

  • 18. Quantitative radioimmunocytochemical evidence that haloperidol and SCH 23390 induce opposite changes in substance P levels of rat substantia nigra.
    Cruz CJ, Beckstead RM.
    Brain Res; 1988 Aug 02; 457(1):29-43. PubMed ID: 2458801
    [Abstract] [Full Text] [Related]

  • 19. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
    Li SJ, Sivam SP, McGinty JF, Huang YS, Hong JS.
    J Pharmacol Exp Ther; 1987 Nov 02; 243(2):792-8. PubMed ID: 2445959
    [Abstract] [Full Text] [Related]

  • 20. Chromatographic evidence for the presence of multiple tachykinins in the bovine adrenal medulla.
    Basile S, Cheung NS, Livett BG.
    J Neurochem; 1992 Apr 02; 58(4):1584-6. PubMed ID: 1372347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.